Partners HealthCare News
Improving Diagnostic Imaging
If you’ve ever tried to take a picture of a squirming baby, you know how tough it can be to get a quality image of something that’s always on the move. A similar challenge can be found in the more advanced imaging tools used in healthcare diagnostics. To capture high-quality images using MRI or PET…
Read More
Klibanski Named Modern Healthcare Top 25 Women Leaders
To view the honor and other women leaders in health care, click here.
Read More
When Your Mentor is Named CEO: Reflections
Last week, Anne Klibanski, MD, CEO of Partners Healthcare, was named one of “The Top 25 Women in Healthcare” by Modern Healthcare. Dr. Klibanski, who has been my mentor since I started my endocrine fellowship in 1995, is clearly an exceptional scientist and a visionary leader. As she received this award, I asked myself, how…
Read More
Anne Klibanski celebrated as CEO and 2019 Top 25 Women Leaders in Health Care by Modern Healthcare
Modern Health Care recently acknowledge the appointment of Anne Klibanski as named first female Partners HealthCare CEO and one of the magazine’s Top 25 Leaders in Healthcare for 2019. We celebrate this recognition and the work of innovative leaders across the healthcare spectrum. Celebrate Accomplishments Women Leaders in Healthcare
Read More
Partners HealthCare names Dr. Anne Klibanski as first-ever female CEO
The Partners HealthCare Board of Directors has named Anne Klibanski, MD President and Chief Executive Officer of Partners HealthCare. Dr. Klibanski becomes the first female chief executive of Partners HealthCare, the state’s largest private employer, with 75,000 employees. Dr. Klibanski was named Interim President and CEO in February. “Over the past several months, it has…
Read More
Health Providers Uncover New Revenue Streams to Advance Innovation For Patient Care
The first benchmarking study of health system efforts to generate new revenue streams evaluates a range of effective strategies to sustain overall operations, fuel innovation, and advance patient care missions. The report by Partners HealthCare and Fitzroy Health finds that successful health systems have increased operating margin as much as five points through diversification strategies.…
Read More
Partners HealthCare names Anne Klibanski, MD, as Interim President and CEO; Recognized by Modern Healthcare as one of 2019’s Top 25 Women Leaders
The Partners HealthCare Board of Directors has named Anne Klibanski, MD, Interim President and Chief Executive Officer of Partners HealthCare. Dr. Klibanski will succeed Dr. David Torchiana, who has served since March 2015 and will retire at the end of April. Earlier this month, Dr. Klibanski was recognized by Modern Healthcare as one of 2019’s…
Read More
Partners HealthCare Chief Clinical Officer Featured in PBS’ “Stories From the Stage”
Eureka! Sometimes that moment of personal discovery comes when you least expect it. Heather Berlin came to a revelation while she dangled 40 feet above the Sydney Zoo; Gregg Meyer, MD discovered how tears could make him a better doctor; and Yari Golden-Castaño’s dream of space flight might just take her to Mars. Three storytellers,…
Read More
An Innovator’s Feast
Save the Date Westin Copley Place | Boston Wednesday, April 10, 2019 This invitation-only reception honors principal investigators and researchers who submitted invention disclosures during the calendar year 2018. The evening features a cocktail reception, live music from a PHS-member band, dinner and a keynote presentation by Alfred Sandrock, MD, PhD, Chief Medical Officer; EVP,…
Read More
Improving Hearing and Vision Leadership at Mass. Eye and Ear
Now that the Mass. Eye and Ear has officially joined Partners, leaders from both organizations are optimistic about the potential to drive new advances in treating blindness, deafness and other debilitating diseases of the head and neck. The move comes at a pivotal time as the promise of gene therapies for inherited eye and ear…
Read MoreAI has arrived- Pharma Times
Artificial intelligence is poised to change the pharmaceutical and healthcare industries as it looks to streamline, speed-up and improve overall efficiency. It might still be early days but it’s a bandwagon that organisations are quickly jumping on board. According to a CB Insights report, about 86% of healthcare organisations, life science companies and med tech…
Read MoreAlexion To Acquire Syntimmune
BOSTON–(BUSINESS WIRE)–Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) and Syntimmune today announced that they have entered into a definitive agreement for Alexion to acquire Syntimmune, a clinical-stage biotechnology company developing antibody therapeutics targeting the neonatal Fc receptor (FcRn). SYNT001 – a humanized monoclonal antibody that inhibits the interaction of FcRn with Immunoglobulin G (IgG) and IgG immune complexes –…
Read MoreU.S. FDA Clears Sebacia Microparticles for the Treatment of Mild to Moderate Inflammatory Acne
Sebacia, Inc., a privately held, commercial stage dermatology and aesthetics company, today announced that the U.S. Food and Drug Administration (FDA) has granted clearance for its lead product, Sebacia Microparticles. This significant achievement is a milestone in the treatment of acne and follows the company’s completion of its pivotal study, which clearly demonstrated clinical efficacy…
Read MoreAKOUOS RAISES $50 MILLION SERIES A FINANCING AND EXPANDS TEAM TO ADVANCE PRECISION GENETIC THERAPIES
Boston, Mass. – August 7, 2018 – Akouos, a precision genetic medicine company developing gene therapies that restore and preserve hearing, today announced the Company has raised $50 million in Series A financing. Seed investors 5AM Ventures and New Enterprise Associates (NEA) co-led the round, and were joined by existing seed investor Partners Innovation Fund and new…
Read MoreTranslate Bio Announces Pricing of Initial Public Offering
Translate Bio, Inc. (Nasdaq: TBIO) a clinical-stage messenger RNA (mRNA) therapeutics company developing a new class of potentially transformative medicines to treat diseases caused by protein or gene dysfunction, today announced the pricing of its initial public offering of 9,350,000 shares of its common stock at a price to the public of $13.00 per share, for total gross…
Read MoreNext Chapter For Biotech? Many Say 'Convergence' With Data Science
by WBUR June 8, 2018- So far, the digital revolution has mostly been a disappointment in health care. Doctors stare at their screens instead of us. Specialists and emergency rooms still don’t have all our records. But artificial intelligence, big data analytics and deep learning are converging on health care in a big way, information…
Read MoreLyndra Inc. and Global Drug Commercialization Center Announce Joint Venture to Develop Lyndra’s Ultra-long-acting Oral Dosage Form for Chinese Market
Lyndra Inc., an emerging biopharmaceutical company, today announced the formation of a joint venture with Global Drug Commercialization Center (GDCC) to commercialize Lyndra’s groundbreaking medicines in China. The partners held a public ribbon-cutting ceremony for the new Lyndra (China) Pharmaceuticals Co., Ltd. headquarters in Chengdu, China. Lyndra is developing ultra-long-acting oral therapies that free patients…
Read MoreMagenta Therapeutics Announces First Patient Transplanted with MGTA-456 in Phase 2 Study in Inherited Metabolic Disorders
Magenta Therapeutics, a biotechnology company developing novel medicines to bring the curative power of bone marrow transplant to more patients, today announced treatment of the first patient with an inherited metabolic disorder in a Phase 2 study of MGTA-456.
Read MorePrinted from https://innovationblog.partners.org/improving-diagnostic-imaging · Published 03 Sep 2019
© PARTNERS HEALTHCARE. ALL RIGHTS RESERVED